KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Change in Account Payables (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Change in Account Payables for 6 consecutive years, with $38.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Account Payables rose 18.08% year-over-year to $38.9 million, compared with a TTM value of -$24.6 million through Sep 2025, down 362.8%, and an annual FY2024 reading of -$19.2 million, down 1035.41% over the prior year.
  • Change in Account Payables was $38.9 million for Q3 2025 at Clover Health Investments, up from $273000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $89.4 million in Q4 2022 and bottomed at -$61.6 million in Q3 2022.
  • Average Change in Account Payables over 5 years is $4.5 million, with a median of $273000.0 recorded in 2025.
  • Peak annual rise in Change in Account Payables hit 1986.24% in 2022, while the deepest fall reached 975.1% in 2022.
  • Year by year, Change in Account Payables stood at -$4.7 million in 2021, then skyrocketed by 1986.24% to $89.4 million in 2022, then crashed by 107.19% to -$6.4 million in 2023, then crashed by 215.55% to -$20.3 million in 2024, then surged by 291.64% to $38.9 million in 2025.
  • Business Quant data shows Change in Account Payables for CLOV at $38.9 million in Q3 2025, $273000.0 in Q2 2025, and -$43.5 million in Q1 2025.